Literature DB >> 6331921

Anergy in sarcoidosis: the role of interleukin-1 and prostaglandins in the depressed in vitro lymphocyte response.

B N Hudspith, J Brostoff, M W McNicol, N M Johnson.   

Abstract

We have shown that peripheral blood monocytes from patients with sarcoidosis release reduced amounts of interleukin-1 (IL-1) when compared with normals. In part, this defect explains the relative in vitro unresponsiveness of T lymphocytes from patients with sarcoidosis as measured by mitogen- or antigen-induced lymphocyte transformation. The addition of supernatants containing pre-formed IL-1 partially restored this defect. This enhancement was found to be additive to the previously described effect of indomethacin, an inhibitor of prostaglandin synthesis. Thus, it would appear that the activated peripheral blood monocytes found in sarcoidosis not only cause reduced lymphocyte proliferation by acting as suppressor cells but are also unable to act as accessory cells in producing IL-1.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331921      PMCID: PMC1536124     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  T gamma cells in sarcoidosis: E rosetting monocytes suppress lymphocyte transformation.

Authors:  N M Johnson; J Brostoff; B N Hudspith; J R Boot; M W McNicol
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

2.  Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases.

Authors:  E C Lawrence; R R Martin; R M Blaese; R B Teague; R J Awe; R K Wilson; W J Deaton; K Bloom; S D Greenberg; P M Stevens
Journal:  N Engl J Med       Date:  1980-05-22       Impact factor: 91.245

3.  Influence of malaria infection on the elaboration of soluble mediators by adherent mononuclear cells.

Authors:  D J Wyler; J J Oppenheim; L C Koontz
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

4.  Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis.

Authors:  P Pinkston; P B Bitterman; R G Crystal
Journal:  N Engl J Med       Date:  1983-04-07       Impact factor: 91.245

5.  The pyrogenic and mitogenic actions of interleukin-1 are related.

Authors:  G W Duff; S K Durum
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

6.  Impaired production of interleukins in patients with cell-mediated immunodeficiencies.

Authors:  R Paganelli; F Aiuti; P C Beverley; R J Levinsky
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

7.  Prostaglandin E2-mediated enhancement of human plasma cell differentiation.

Authors:  P M Lydyard; J Brostoff; B N Hudspith; H Parry
Journal:  Immunol Lett       Date:  1982-03       Impact factor: 3.685

8.  Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s).

Authors:  I Gery; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

9.  Prostaglandin E inhibits the production of human interleukin 2.

Authors:  R S Rappaport; G R Dodge
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

10.  The functional relationship of the interleukins.

Authors:  K A Smith; L B Lachman; J J Oppenheim; M F Favata
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

  10 in total
  9 in total

1.  Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis.

Authors:  T Jakob; B N Huspith; Y E Latchman; R Rycroft; J Brostoff
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

2.  Serum C-reactive protein concentrations in patients with pulmonary sarcoidosis.

Authors:  C R Hind; K C Flint; B N Hudspith; D Felmingham; J Brostoff; N M Johnson
Journal:  Thorax       Date:  1987-05       Impact factor: 9.139

3.  Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Ali Kanchwala; Carter J H Childs; Yash P Kataria; Marc A Judson; Mark A Mazer; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

4.  Defective interleukin-1 production in a familial monocyte disorder with a combined abnormality of mobility and phagocytosis-killing.

Authors:  A Komiyama; M Ichikawa; H Kanda; K Aoyama; K Yasui; M Yamazaki; H Kawai; Y Miyagawa; T Akabane
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

5.  Release in vivo of IL-1 like activity by human skin.

Authors:  P M Dowd; B N Hudspith; J A Miller; R M Barr; J Brostoff; M W Greaves
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

6.  Interleukin 1 in Crohn's disease.

Authors:  J Satsangi; R A Wolstencroft; J Cason; C C Ainley; D C Dumonde; R P Thompson
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

7.  Lack of immune deficiency in sarcoidosis: compartmentalisation of the immune response.

Authors:  B N Hudspith; K C Flint; D Geraint-James; J Brostoff; N M Johnson
Journal:  Thorax       Date:  1987-04       Impact factor: 9.139

8.  Monocyte factors modulate in vitro T-lymphocyte mitogenesis in protein malnutrition.

Authors:  R C Bell; L Hoffman-Goetz; R Keir
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

9.  Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.

Authors:  Elisabeth Oelmann; Harald Stein; Wolfgang E Berdel; Hermann Herbst
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.